阿扑吗啡
左旋多巴
医学
安慰剂
麻醉
不利影响
帕金森病
多巴胺能
止痛药
可视模拟标度
评定量表
脑深部刺激
临床试验
临床终点
临床全球印象
皮下注射
运动障碍
中枢神经系统疾病
神经系统疾病
随机对照试验
物理疗法
多巴胺激动剂
普拉克索
卡比多巴
多巴胺
退行性疾病
作者
Parisa Alizadeh,Ali H. Abusrair,Gabriel Amorelli,Kinza Naser,Alicja Cieślak,Beatrice Achen,Nancy Labelle,Tracy Hammer,Veronica Andrea Bruno
标识
DOI:10.1097/wnf.0000000000000699
摘要
BACKGROUND: OFF-related pain is a disabling and underrecognized nonmotor symptom of Parkinson disease. Oral dopaminergic therapy may provide inconsistent relief due to erratic gastrointestinal absorption and fluctuating levodopa levels. Subcutaneous apomorphine, a rapid-acting dopamine agonist, may represent a rational rescue strategy. METHODS: We conducted a single-center, randomized, double-blind, placebo-controlled, 2-period cross-over pilot trial in Parkinson disease patients with motor fluctuations and reproducible OFF-related pain. Participants received subcutaneous apomorphine (2 mg followed by 3 mg) and placebo on separate visits 1 week apart during defined OFF states established by withholding antiparkinsonian medications overnight for at least 12 hours. The primary outcome was the change in pain severity measured by visual analogue scale (VAS) 30 minutes after the 3 mg dose (90 min from baseline). Secondary outcomes included Movement Disorder Society-Unified Parkinson Disease Rating Scale Part III (MDS-UPDRS Part III) scores, Clinical Global Impression (CGI), and adverse events. RESULTS: Eleven participants were randomized; 10 completed both treatment periods. At the primary endpoint (n=7 paired), apomorphine produced greater pain reduction than placebo (Hodges-Lehmann median difference -3.85; 95% CI: -6.90 to -1.85; P=0.016; dz=1.57). Motor improvement paralleled analgesic response and correlated with pain reduction (ρ=0.68; P=0.030). Adverse events were mild and comparable between treatments. CONCLUSIONS: Subcutaneous apomorphine was associated with clinically meaningful improvements in OFF-related pain and motor symptoms in this pilot cross-over trial. These findings support further evaluation of dopaminergic rescue therapy as a potential treatment strategy in larger studies.
科研通智能强力驱动
Strongly Powered by AbleSci AI